卒中或短暂性脑缺血发作后的牙周病治疗:PREMIERS研究,一项随机临床试验
这项多中心II期试验将280例近期卒中/短暂性脑缺血发作合并中度严重牙周病的患者随机分为强化牙周治疗组(n=140)和标准牙周治疗组(n=140)。12个月内主要结局(死亡、心肌梗死、复发性卒中复合终点)在强化组发生11例(8%),标准组17例(12%),强化组不优于标准组(HR 0.65 [95% CI 0.30-1.38])。两组不良事件发生率相似,次要结局中舒张压和高密度脂蛋白胆固醇在两组均有改善(P<0.05)。
要点
- 强化牙周治疗在预防卒中/心肌梗死/死亡方面不优于标准牙周治疗(HR 0.65 [95% CI 0.30-1.38])。
- 12个月内主要结局强化组11例(8%)vs标准组17例(12%),强化组事件数较少。
- 两组安全性结局相当,舒张压和高密度脂蛋白胆固醇在两组均有显著改善(P<0.05)。
核心结论
- 在近期卒中/短暂性脑缺血发作合并牙周病的患者中,强化牙周治疗在预防卒中/心肌梗死/死亡方面不优于标准牙周治疗。
- 强化组事件数较少,两组安全性结局相当。
- 次要结局指标显示改善趋势,舒张压和高密度脂蛋白胆固醇在两组治疗中均有显著变化。
研究设计与样本
- 多中心II期随机临床试验,纳入近期卒中/短暂性脑缺血发作合并中度严重牙周病的患者。
- 共筛查1209例卒中/短暂性脑缺血发作患者,其中481例符合牙周病入选标准,280例随机分配至强化牙周治疗组(n=140)和标准牙周治疗组(n=140)。
主要发现
- 12个月内主要结局(死亡、心肌梗死、复发性卒中复合终点)在强化组发生11例(8%),标准组发生17例(12%)。
- 强化组不优于标准组(风险比0.65 [95% CI 0.30-1.38])。
- 不良事件发生率相似:脓毒症强化组2.1% vs 标准组0.7%;牙出血强化组1.4% vs 标准组0%;感染性心内膜炎强化组0.7% vs 标准组0%。
- 次要结局在两组均有改善,舒张压和高密度脂蛋白胆固醇变化有统计学意义(P<0.05)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with stroke/transient ischemic attack and periodontal disease (PD) are at increased risk for cardiovascular events. PD treatments that can improve stroke risk factors were tested if they might assist patients with cerebrovascular disease. METHODS: In this multicenter phase II trial, patients with stroke/transient ischemic attack and moderately severe PD were randomly assigned to intensive or standard PD treatment arms. The primary outcome measure was a composite of death, myocardial infarction, and recurrent stroke, as well as adverse events. Secondary outcome included changes in stroke risk factors. RESULTS: A total of 1209 patients with stroke/transient ischemic attack were screened, of whom 481 met the PD eligibility criteria; 280 patients were randomized to intensive arm (n=140) and standard arm (n=140). In 12-month period, primary outcome occurred in 11 (8%) in the intensive arm and 17 (12%) in the standard arm. The intensive arm was nonsuperior to the standard arm (hazard ratio, 0.65 [95% CI, 0.30-1.38]) with similar rates of adverse events (sepsis 2.1% versus 0.7%; dental bleeding 1.4% versus 0%; and infective endocarditis 0.7% versus 0%). Secondary-outcome improvements were noted in both arms with diastolic blood pressure and high-density lipoprotein cholesterol (P<0.05). CONCLUSIONS: In patients with recent stroke/transient ischemic attack and PD, intensive PD treatment was not superior to standard PD treatment in prevention of stroke/myocardial infarction/death. Fewer events were noted in the intensive arm and the 2 arms were comparable in the safety outcomes. Secondary-outcome measures showed a trend toward improvement, with significant changes noted in diastolic blood pressure and high-density lipoprotein in both the treatment arms.
引用
- Sen S, Curtis J, Hicklin D, et al. Periodontal Disease Treatment After Stroke or Transient Ischemic Attack: The PREMIERS Study, a Randomized Clinical Trial. Stroke. 2023. PMID: 37548008. doi:10.1161/STROKEAHA.122.042047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。